Compare Consolidated Edison, Inc. (ED) vs Inovio Pharmaceuticals Inc (INO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Consolidated Edison, Inc. vs Inovio Pharmaceuticals Inc — how do they compare? Consolidated Edison, Inc. trades at $107.5 (market cap $39.76B), while Inovio Pharmaceuticals Inc trades at $0.8 (market cap $78.55M). The key difference: Consolidated Edison, Inc. is far larger — about 506.2× Inovio Pharmaceuticals Inc's market cap, and Consolidated Edison, Inc. pays a 3.27% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| ED | INO | |
|---|---|---|
Market Cap | $39.76B | $78.55M |
Sector | Utilities | Health |
52-Week High | $115.46 | $2.87 |
52-Week Low | $95.37 | $0.66 |
Enterprise Value | $66.61B | $49.56M |
Dividend Yield | 3.27% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Consolidated Edison, Inc.
Con Ed is a holding company for Consolidated Edison of New York, or CECONY, and Orange & Rockland, or O&R. These utilities provide steam, natural gas, and electricity to customers in southeastern New York—including New York City—and small parts of New Jersey. The two utilities will generate nearly all of Con Ed's earnings once it closes the sale of its clean energy business to RWE. Con Ed's clean energy business owns the second-largest portfolio of utility-scale solar projects in the U.S. Following the sale, Con Ed's only non-utility earnings will come from investments in gas and electric transmission.
Read more on ED →About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →
